CA
NZ
UK
AU
IND
US
Tenet Healthcare Corp (NYSE: THC). has seen its stock price stabilize at $259.45, marking a significant 30.1% appreciation this year as the company pushes its growth initiatives. Investors are encouraged by this upward trend after the stock had fluctuated within a 52-week range of …
TimelyCare, recognized as a leader in virtual healthcare, made headlines by ranking 2,964 on the Inc. 5000 list, reflecting a 104% revenue growth over three years. This recognition, which marks the fifth consecutive year on the list, underscores the increasing demand for accessible health …
Sintx Technologies, Inc. (NASDAQ: SINT) posted a second-quarter loss of $-0.75 per share, underperforming relative to the consensus estimate of $-0.69. This financial setback occurs amid a significant decline in the stock price, which has dropped by 53.2% year-to-date, suggesting a turbulent period ahead …
Tango Therapeutics, Inc. (NASDAQ: TNGX) has significantly raised its potential stock offering to an aggregate price of up to $400 million, following a successful prior program. Having previously raised an estimated $64 million, the company now aims to enhance its financial flexibility with this …
Taysha Gene Therapies, Inc. (NASDAQ: TSHA) reported a net loss of $46.6 million for the second quarter of 2026, translating to $0.13 per share. This loss represents a significant increase from the $26.9 million loss reported in the same quarter a year ago. The …
Sanara MedTech Inc. (NASDAQ: SMTI) reported a notable increase in its second-quarter revenue, reaching $28.1 million, representing a 9% growth compared to $25.8 million in Q2 2025. The increase in revenue indicates a strong performance by the medical technology company, particularly in its soft …
Seer (NASDAQ: SEER) reported $209.5 million in cash and investments at the end of Q2, an amount that dwarfs its $119 million market capitalization by 176 %.
NovelMed Therapeutics, Inc. is making significant strides with NM5072, a candidate for treating various ocular disorders. The biotechnology company reported compelling results from preclinical studies, particularly in reducing choroidal neovascularization (CNV), which is important for conditions like age-related macular degeneration (AMD). The drug's efficacy …
Village Farms International reported significant growth results, highlighted by a $15 million equity placement secured from U.S. institutional investors, boosting both financial stability and institutional ownership. This strategic move is timely as the company navigates a dynamic market for cannabis products, particularly with record …
Monopar Therapeutics (NASDAQ: MNPR) faced a net loss of $5.3 million for the second quarter of 2026, translating to $0.62 per share. This ongoing financial recovery highlights the company's increasing stability amidst ongoing developments in its drug pipeline, particularly for ALXN1840, which is progressing …
Please wait processing your request...